Skip to main content
. 2015 May 14;35(6):375–384. doi: 10.1007/s40261-015-0291-9

Fig. 2.

Fig. 2

Mean total percentage (±standard deviation) recovery of fecal excretion of fidaxomicin plus OP-1118 versus nominal time at Day 1 after single-dose administration of fidaxomicin in Japanese subjects and Caucasian subjects. The percentage fecal cumulative excretion of OP-1118 was adjusted by multiplying by the ratio: [fidaxomicin molecular weight (1058.04)/OP-1118 molecular weight (987.95) × dose]